Passage Bio to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
PHILADELPHIA, April 22, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ:PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced
GlobeNewswireApr 22 07:00 ET
Analysts' Top Healthcare Picks: Wave Life Sciences (WVE), Passage Bio (PASG)
TipRanksApr 1 07:21 ET
Analysts Are Bullish on Top Healthcare Stocks: Quanterix (QTRX), Passage Bio (PASG)
TipRanksMar 26 07:20 ET
Express News | Canaccord Genuity Reiterates Buy on Passage Bio, Maintains $14 Price Target
Moomoo 24/7Mar 5 09:03 ET
Passage Bio Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/05/2024 723.53% Canaccord Genuity → $14 Reiterates Buy → Buy 11/14/2023 194.12% Raymond James $9 → $5 M
BenzingaMar 5 09:01 ET
New Innovation / R&D Risk for Passage Bio, Inc. – What's the Latest?
TipRanksMar 5 01:01 ET
Passage Bio Files for $200M Mixed Shelf Offering
Seeking AlphaMar 4 16:21 ET
Passage Bio GAAP EPS of -$1.86 Beats by $0.04
Seeking AlphaMar 4 07:36 ET
Express News | Passage Bio Tapped Kathleen Borthwick as CFO, Effective March 1
Moomoo 24/7Mar 4 07:07 ET
Passage Bio: Runway To Fund Operations Into 4Q 2025 >PASG
Passage Bio: Runway To Fund Operations Into 4Q 2025 >PASG
Dow JonesMar 4 07:02 ET
Passage Bio 4Q Loss $16.8M >PASG
Passage Bio 4Q Loss $16.8M >PASG
Dow JonesMar 4 07:01 ET
Passage Bio 4Q Loss/Shr 30c >PASG
Passage Bio 4Q Loss/Shr 30c >PASG
Dow JonesMar 4 07:01 ET
Passage Bio to Participate in Upcoming Investor Conferences
PHILADELPHIA, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ:PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced
GlobeNewswireFeb 27 07:00 ET
Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
PHILADELPHIA, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ:PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced
GlobeNewswireJan 31 07:30 ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersInspire Veterinary (NASDAQ:IVP) stock moved upwards by 178.9% to $0.52 during Friday's pre-market session. The company's market cap stands at $5.7 million. Aclarion (NASDAQ:ACON) stock increase
BenzingaJan 26 08:05 ET
12 Health Care Stocks Moving In Monday's After-Market Session
GainersCadrenal Therapeutics (NASDAQ:CVKD) shares moved upwards by 8.5% to $1.15 during Monday's after-market session. The market value of their outstanding shares is at $14.9 million. vTv Therapeutic
BenzingaJan 22 16:31 ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersTalphera (NASDAQ:TLPH) stock moved upwards by 10.5% to $0.85 during Wednesday's after-market session. The company's market cap stands at $14.4 million. Windtree Therapeutics (NASDAQ:WINT) share
BenzingaJan 17 16:31 ET
Passage Bio Says Data From Phase 1/2 Trial of Dementia Therapy Exceeded Expectations
Passage Bio (PASG) said Wednesday data from the phase 1/2 trial evaluating PBFT02, a therapy for the treatment of dementia, exceeded expectations, prompting the company to explore the potential for us
MT NewswiresDec 20, 2023 16:36 ET
Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), OrganiGram Holdings (OGI) and Passage Bio (PASG)
TipRanksDec 20, 2023 15:11 ET
Passage Bio Stock Climbs 9% on Dementia Study, Program Update
Seeking AlphaDec 20, 2023 14:20 ET
No Data
No Data